DrugPatentWatch Database Preview
Patent: 9,051,582
» See Plans and Pricing
Summary for Patent: 9,051,582
| Title: | Expression vectors comprising the mCMV IE2 promoter |
| Abstract: | The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression enhancing fragment thereof, wherein the expression vector does not contain any complete gene of the mCMV. |
| Inventor(s): | Chatellard; Philippe (Lausanne, CH), Imhof; Markus (Chexbres, CH) |
| Assignee: | MERCK SERONO SA (Coinsins, Vaud, CH) |
| Application Number: | 12/872,151 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,051,582
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | MERCK SERONO SA (Coinsins, Vaud, CH) | 2023-03-11 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | MERCK SERONO SA (Coinsins, Vaud, CH) | 2023-03-11 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | MERCK SERONO SA (Coinsins, Vaud, CH) | 2023-03-11 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,051,582
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200506400 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2004081167 | Start Trial |
| United States of America | 2007258962 | Start Trial |
| United States of America | 2011008839 | Start Trial |
| United States of America | 2015252383 | Start Trial |
| United States of America | 7824907 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
